Cargando…

CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales

INTRODUCTION: Earlier diagnosis of neurocognitive disorders and neurodegenerative disease is needed to implement preventative interventions, minimize harm, and reduce risk of exploitation in the context of undetected disease. Along the spectrum from subjective cognitive decline (SCD) to dementia, ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang‐Wai, David F., Smith, Eric E., Bruneau, Marie‐Andrée, Burhan, Amer M., Chatterjee, Atri, Chertkow, Howard, Choudhury, Samira, Dorri, Ehsan, Ducharme, Simon, Fischer, Corinne E., Ghodasara, Sheena, Herrmann, Nathan, Hsiung, Ging‐Yuek Robin, Kumar, Sanjeev, Laforce, Robert, Lee, Linda, Massoud, Fadi, Shulman, Kenneth I., Stiffel, Michael, Gauthier, Serge, Ismail, Zahinoor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Special Topic Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657153/ https://www.ncbi.nlm.nih.gov/pubmed/33209972 http://dx.doi.org/10.1002/trc2.12057

Ejemplares similares

CCCDTD5: research diagnostic criteria for Alzheimer's Disease
por: Gauthier, Serge, et al.
Publicado: (2020)

CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
por: Herrmann, Nathan, et al.
Publicado: (2022)

Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
por: Gauthier, Serge, et al.
Publicado: (2012)

CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
por: Brisson, Mélanie, et al.
Publicado: (2021)

Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
por: Smith, Eric E., et al.
Publicado: (2020)

Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
por: Chatterjee, Atri, et al.
Publicado: (2021)

CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus
por: Montero‐Odasso, Manuel, et al.
Publicado: (2020)

CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5)
por: Rockwood, Kenneth, et al.
Publicado: (2020)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

CCCDTD5: Individual and community‐based psychosocial and other non‐pharmacological interventions to support persons living with dementia and their caregivers
por: Vedel, Isabelle, et al.
Publicado: (2020)

Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians
por: Rosa-Neto, Pedro, et al.
Publicado: (2013)

Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia
por: Chertkow, Howard, et al.
Publicado: (2013)

THE ROLE OF S100B IN AEROBIC TRAINING EFFICACY IN OLDER ADULTS WITH MILD VASCULAR COGNITIVE IMPAIRMENT
por: Crockett, Rachel A, et al.
Publicado: (2019)

AEROBIC TRAINING, THE DEFAULT MODE NETWORK, AND COGNITION IN OLDER ADULTS WITH MILD VASCULAR COGNITIVE IMPAIRMENT
por: Crockett, Rachel A, et al.
Publicado: (2019)

Early-onset dementias: diagnostic and etiological considerations
por: Masellis, Mario, et al.
Publicado: (2013)

Cardiovascular risk moderates the effect of aerobic exercise on executive functions in older adults with subcortical ischemic vascular cognitive impairment
por: Barha, Cindy K., et al.
Publicado: (2021)

An automated clinical mass spectrometric method for identification and quantification of variant and wild‐type amyloid‐β 1‐40 and 1‐42 peptides in CSF
por: DeMarco, Mari L., et al.
Publicado: (2020)

Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
por: Ismail, Zahinoor, et al.
Publicado: (2020)

Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment
por: Dao, Elizabeth, et al.
Publicado: (2017)

Update on the Pharmacological Treatment of Alzheimer’s Disease
por: Massoud, Fadi, et al.
Publicado: (2010)

White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers
por: Lee, Hyunwoo, et al.
Publicado: (2022)

Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
por: Dao, Elizabeth, et al.
Publicado: (2015)

Erratum to: Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
por: Dao, Elizabeth, et al.
Publicado: (2016)

Agreement between Patient and Proxy Assessments of Quality of Life among Older Adults with Vascular Cognitive Impairment Using the EQ-5D-3L and ICECAP-O
por: Davis, Jennifer C., et al.
Publicado: (2016)

The Association Between Obstructive Sleep Apnea and Alzheimer’s Disease: A Meta-Analysis Perspective
por: Emamian, Farnoosh, et al.
Publicado: (2016)

Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging
por: Popuri, Karteek, et al.
Publicado: (2018)

Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment
por: Liu-Ambrose, Teresa, et al.
Publicado: (2010)

Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Burhan, Amer M, et al.
Publicado: (2013)

Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Soucy, Jean-Paul, et al.
Publicado: (2013)

Detection of cognitive impairment using a machine-learning algorithm
por: Youn, Young Chul, et al.
Publicado: (2018)

Diagnostic criteria for apathy in neurocognitive disorders
por: Miller, David S., et al.
Publicado: (2021)

Economic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial
por: Davis, Jennifer C, et al.
Publicado: (2017)

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
por: Lanctôt, Krista L., et al.
Publicado: (2023)

FDG-PET in presymptomatic C9orf72 mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2021)

Protocol for validating an algorithm to identify neurocognitive disorders in Canadian Longitudinal Study on Aging participants: an observational study
por: Mayhew, Alexandra J, et al.
Publicado: (2023)

Effects of low-level laser therapy on orthodontic tooth movement and root resorption after artificial socket preservation
por: Seifi, Massoud, et al.
Publicado: (2014)

Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment
por: Cloutier, Simon, et al.
Publicado: (2015)

Canadian Academy of Geriatric Psychiatry Survey of Brief Cognitive Screening Instruments
por: Ismail, Zahinoor, et al.
Publicado: (2013)

Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2018)

Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial
por: Liu-Ambrose, Teresa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_06gb0bb5jqt44bb6eeto35n71c